ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2015

GRP78 and α2-macroglobulin are new promising targets for metastatic castrate-resistant prostate cancer treatment.

P J Vlachostergios et al.PubMed ↗Publisher ↗

No numbers read from the abstract.